Search results :

Entecavir

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: J05AF10

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7
Oedema peripheral Oedema peripheral 16% x x
Ascites Ascites 15% x x
Body temperature increased Body temperature increased 14% x x
Hepatic encephalopathy Hepatic encephalopathy 10% x x
Upper respiratory tract infection Upper respiratory tract infection 10% x x
Haematuria Haematuria 6% - 10% x x x
Glycosuria Glycosuria 3% - 6% x x x x
Asthenia Fatigue common, 1% - 6% x x x x x x x
Fatigue Fatigue common, 1% - 6% x x x x x x x
Abdominal pain upper Abdominal pain upper postmarketing, 2% - 5% x
Headache Headache common, 1% - 9% x x x x x x x
Nausea Nausea uncommon — 1% - 3% x x x x x x x
Blood bicarbonate decreased Blood bicarbonate decreased 2% x x x
Dizziness Dizziness uncommon — 1% - 4% x x x x x x x
Hyperglycaemia Hyperglycaemia 1% - 2% x x x x
Diarrhoea Diarrhoea uncommon — 0% - 1% x x x x x x x
Dyspepsia Dyspepsia uncommon — 0% - 2% x x x x x x x
Renal failure Renal failure 1% x x x
Vomiting Vomiting uncommon — 0% - 1% x x x x x x x
Insomnia Insomnia uncommon — 0% - 2% x x x x x x x
Somnolence Somnolence uncommon — 0% - 1% x x x x x x x
Lactic acidosis Lactic acidosis postmarketing, common x x x x x
Alopecia Alopecia postmarketing, uncommon x x x x
Dermatitis Rash postmarketing, uncommon x x x x x x x
Rash Rash postmarketing, uncommon x x x x x x x
Gastrointestinal disorder Gastrointestinal disorder postmarketing, common x x x
Immune system disorder Immune system disorder postmarketing x x x x x
Lactose intolerance Lactose intolerance postmarketing x
Lactase deficiency Lactose intolerance postmarketing x
Leukopenia Leukopenia postmarketing x
Neutropenia Neutropenia postmarketing x
Pancreatitis Pancreatitis postmarketing x
Malnutrition Malnutrition postmarketing x x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x x x
Hepatobiliary disease Hepatobiliary disease postmarketing, common x x x x
Anaphylactic shock Anaphylactoid reaction postmarketing, rare x x x x x
Anaphylactoid reaction Anaphylactoid reaction postmarketing, rare x x x x x
Platelet count decreased Platelet count decreased postmarketing x
Transaminases increased Transaminases increased postmarketing, common x x x x
Hepatic cirrhosis Decompensated cirrhosis postmarketing x
Abdominal pain Abdominal pain x
Gastrointestinal pain Abdominal pain x
Mental disorder Mental disorder x x
Hepatitis Hepatitis x x x x x x x
Hepatitis B Hepatitis B x
Hepatomegaly Hepatomegaly x x x
Hepatorenal syndrome Hepatorenal syndrome x x
Immunodeficiency Immunodeficiency x
Nervous system disorder Nervous system disorder x x
Upper gastrointestinal haemorrhage Upper gastrointestinal haemorrhage x x
Viraemia Viraemia x x x x
Hepatic failure Hepatic failure x x
Infection Infection mixed x x
Hepatitis B e antigen positive Hepatitis B e antigen positive x x x
Laboratory test abnormal Laboratory test abnormal x x x x x
Blood creatinine increased Serum creatinine increased x x
Hepatic cancer Hepatocellular carcinoma x x x x
Hepatocellular carcinoma Hepatocellular carcinoma x x x x
Product taste abnormal Product taste abnormal x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

ENTECAVIR / BARACLUDE

Side effects:26
Source:Health Canada

entecavir / Baraclude

Side effects:15
Source:FDA

ENTECAVIR / BARACLUDE

Side effects:21
Source:FDA

entecavir / entecavir

Side effects:22
Source:EMA

entecavir / Baraclude, Film coated tablet

Side effects:31
Source:Medsafe

ENTECAVIR ANHYDROUS

Side effects:36
Source:FDA Structured Product Label

entecavir anhydrous

Side effects:39
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label